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           The clinical manifestations of HIV infection typi-
cally ensue years after primary infection, despite 
continuous, often very high levels of viral repli-
cation (  1  –  3  ). Although viral replication clearly 
drives the development of overt disease (  1, 3, 4  ), 
the slow tempo of progression implies that host 
mechanisms must participate in the pathogenic 
sequence. Over years of investigation, a wide 
  variety of pathogenic mechanisms have been 
proposed to play a role in AIDS pathogenesis in 
humans and AIDS-susceptible Asian macaques, 
including direct viral cytopathogenicity on CD4      
T cells and/or other target cells, indirect eff  ects 
of infection such as persistent immune   “  hyper-
activation,  ”   and other forms of T cell or accessory 
cell dysregulation (  1, 5  –  12  ), but the degree to 
which these various mechanisms   “  connect  ”   HIV 
or simian immunodefi  ciency virus (SIV) replica-
tion to immunodefi  ciency, as well as their inter-
action and regulation, remains poorly defi  ned. 
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  Primary simian immunodefi  ciency virus (SIV) infections of rhesus macaques result in the 
dramatic depletion of CD4      CCR5      effector  –  memory T (T  EM  ) cells from extra-lymphoid 
effector sites, but in most infections, an increased rate of CD4      memory T cell proliferation 
appears to prevent collapse of effector site CD4      T  EM   cell populations and acute-phase 
AIDS. Eventually, persistent SIV replication results in chronic-phase AIDS, but the respon-
sible mechanisms remain controversial. Here, we demonstrate that in the chronic phase of 
progressive SIV infection, effector site CD4      T  EM   cell populations manifest a slow, continu-
ous decline, and that the degree of this depletion remains a highly signifi  cant correlate of 
late-onset AIDS. We further show that due to persistent immune activation, effector site 
CD4      T  EM   cells are predominantly short-lived, and that their homeostasis is strikingly depen-
dent on the production of new CD4      T  EM   cells from central  –  memory T (T  CM  ) cell precursors. 
The instability of effector site CD4      T  EM   cell populations over time was not explained by 
increasing destruction of these cells, but rather was attributable to progressive reduction 
in their production, secondary to decreasing numbers of CCR5         CD4      T  CM   cells. These data 
suggest that although CD4      T  EM   cell depletion is a proximate mechanism of immuno-
defi  ciency, the tempo of this depletion and the timing of disease onset are largely determined 
by destruction, failing production, and gradual decline of CD4      T  CM   cells. 2172 DETERMINANTS OF PROGRESSION IN CHRONIC SIV INFECTION | Okoye et al.
    RESULTS   
  CD4      memory T cell depletion in extra-lymphoid effector 
sites correlates with overt disease 
  SIVmac239 and related CCR5-tropic SIVs are highly patho-
genic for Indian origin RMs, inducing rapid disease progression 
(AIDS in      200 d) in     25% of infected animals and normal 
progression (AIDS in 1  –  3 yr) in the majority of the remainder 
(  27  ).   Fig. 1   A shows plasma viral loads (pvls) over the course of 
infection of 14 SIVmac239-infected RMs that did not receive 
antiretroviral therapy (ART) and were followed to an AIDS 
endpoint (4 rapid progressors and 10 normal progressors).   As 
reported previously (  15  ), rapid progressors manifest 1  –  2 log 
higher pvls than RMs destined for  350 d survival. However, 
among the latter group, plateau-phase pvls did not distinguish 
between RMs with considerably diff  erent survival periods. In-
deed, when the entire study group was included in a correlation 
analysis of plateau-phase pvls versus time to endpoint, a signi-
fi  cant association was observed (by either parametric or non-
parametric analysis); however, when the four rapid progressors 
were excluded from the analysis, this association was no longer 
apparent (  Fig. 1 B  ). Moreover, in all the normal progressors, 
pvls remained steady through the development of overt disease. 
  Primary CXCR4- or dual-tropic SIV/HIV hybrid virus 
(SHIV) infection can induce pan-CD4      T cell depletion and 
early immune defi  ciency in rhesus macaques (RMs), suggesting 
that acute, massive destruction of CD4      T cells can directly 
lead to AIDS (  13, 14  ). However, pan-CD4      T cell depletion 
is unusual for typical CCR5-tropic SIV infection and is clearly 
not required for AIDS to develop (  15, 16  ). The CCR5 co-
receptor is selectively expressed on (CCR7    −   ) eff  ector site (or 
eff  ector site  –  seeking) eff  ector  –  memory T (T  EM  ) cells (  9, 17, 18  ), 
and in keeping with this, CCR5-tropic HIV/SIV infection 
dramatically depletes extra-lymphoid eff  ector sites of their 
CD4      T  EM   cell complement during acute infection (  12, 19  –  23  ). 
In most infected monkeys and humans, this acute phase deple-
tion does not result in overt immunodefi  ciency because in 
contrast to the pan-CD4      T cell-depleting SHIVs, CCR5-
  tropic viruses leave a substantial CD4      central  –  memory T 
(T  CM  ) cell population intact, and the CD4      T  EM   cell depletion 
is accompanied by increased proliferation of these spared CD4      
memory T cells that continuously provides an infl  ux of new 
CD4      T  EM   cells into extra-lymphoid eff  ector sites (  15, 23  ). 
Because failure of this CD4      memory T cell  –  proliferative re-
sponse was a strong correlate of early AIDS onset (  15  ), CD4      
T  EM   cell dynamics appear to be a major determinant of immuno-
competence in acute CCR5-tropic SIV infection, with clinical 
immunodefi  ciency requiring both the destruction of extant 
T  EM   cells and a failure to replenish these cells above a critical 
threshold (  15, 23  ). 
  Whereas rapid progression results from a relatively abrupt, 
inadequately compensated alteration of a normal immune sys-
tem, chronic AIDS is thought to result from a slow, progressive 
deterioration of a quasi-stable steady-state characterized by on-
going CD4      T cell death and regeneration, and in particular, 
a pervasive, chronic immune activation that has been shown 
to be a strong predictor of the tempo of progression (  10  –  12, 
24  –  26  ). The question therefore arises as to whether a sustained 
or increasing CD4      T  EM   cell defi  cit continues to play a primary 
pathogenic role, and if so, whether and how direct viral cyto-
pathogenicity, immune activation, and/or other factors con-
tribute to this defi  cit. Here, we address these questions with a 
detailed analysis of the development of AIDS in RMs chroni-
cally infected with SIVmac239. Our results continue to strongly 
implicate the inability to maintain CD4      T cell populations in 
extra-lymphoid eff  ector sites above a critical threshold as the 
common fi  nal pathway in the development of AIDS. How-
ever, direct viral destruction of eff  ector site CD4      T  EM   cell 
populations did not appear to be the determining mechanism 
of AIDS onset. Rather, we found that persistent immune acti-
vation renders these populations highly dependent on the pro-
liferation and diff  erentiation of (CCR5    −   ) T  CM   cells for their 
homeostasis, and that this CD4      T  CM   cell  –  derived, T  EM   cell 
production progressively declines in chronic infection. Thus, 
although CD4      T  EM   cells are the primary targets of HIV/SIV 
infection, our data suggest that the direct and indirect eff  ects 
of infection on the less effi   ciently targeted CD4      T  CM   cell 
population determine the tempo of disease progression during 
chronic infection. 
  Figure 1.     Relationship between pvl and survival in SIVmac239 
infection. (A) Pvl data is shown for 14 SIVmac239-infected RMs that did 
not receive ART during their course and were followed to an AIDS end-
point. Profi  les are color-coded according to time to endpoint as indicated. 
Note that the y axis starts at 10  2   copies/ml (the threshold sensitivity of 
the viral load assay) rather than 0 (acute-phase viral load data on these 
RM can be viewed in detail in reference   15  ). (B) The mean pvl for each RM 
from postinfection day (PID) 70 to either endpoint (rapid progressors) or 
PID 350 (normal progressors) is plotted against time to AIDS for all 14 
RMs (left) or the 10 normal progressors alone (right). The graph confi  gu-
ration and color-coding are as described for A. Both linear regression (R) 
and Spearman rank (Rho) correlation coeffi  cients and the p-values for 
these analyses are indicated in each plot. NS, nonsignifi   cant.   JEM VOL. 204, September 3, 2007 
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tissue defi  cits and prevents immunological collapse (  15  ). As 
it is possible that the same mechanisms extend to chronic 
progression, we asked fi  rst whether CD4      T  EM   cell depletion 
was a specifi  c and uniform feature of SIVmac239-mediated 
AIDS ( Fig. 2 ).   Because almost all bronchoalveolar lavage (BAL) 
T cells manifest the phenotypic signature, CCR7         and/or 
CCR5     , of T  EM   cells (  18, 23  ), the fate of CD4      T cells in this 
site provides insight into the extra-lymphoid CD4      T  EM   cell 
compartment. As shown in   Fig. 2 A  , analysis of 13 normal 
progressors and 4 rapid progressors demonstrated that overt 
disease in both settings was uniformly associated with a striking 
(     99%) decline in CD4      T cell representation among BAL 
T  EM   cells. Because total lymphocyte recovery from BAL in 
later stages of infection was comparable to or reduced from 
preinfection (unpublished data), this decline predominantly 
represents CD4      T  EM   cell depletion, rather than CD8      T  EM   
Thus, within the range of viral replication manifested by typical 
SIV-infected normal progressors, the time to disease was not 
closely linked to mean pvls over time nor to any late accelera-
tion of viral replication, observations suggesting that the rate of 
disease progression in these RMs was largely determined by 
their ability to handle the consequences of chronic viral replica-
tion, rather than by diff  erences in viral replication itself. 
  A major consequence of acute CCR5-tropic SIV infection 
is destruction of CD4      memory T cells, particularly CD4      
T  EM   cells in extra-lymphoid eff  ector sites, and we have previ-
ously shown that a strong immunologic correlate of rapid 
  progression is the failure to follow this initial CD4      T  EM   cell 
depletion with a sustained increase in the fraction of proliferat-
ing CD4      memory T cells (  15  ). This increase provides   “  tar-
gets  ”   for SIV (  12, 20  ), but also contributes to the continuous 
production of new CD4      T  EM   cells that limits extra-lymphoid 
  Figure 2.     Systemic analysis of T cell populations in SIVmac239-infected RMs with overt immunodefi  ciency. (A) The absolute number of total, 
memory, and naive CD4      and  CD8     T cells in the blood and the percent CD4      T cells (of total CD3     ) in BAL were evaluated by fl  ow cytometry at the time 
of infection (baseline) and at an AIDS endpoint in 17 SIVmac239-infected RMs: 4 rapid progressors (red) and 13 normal progressors (black). Results are 
presented as percent change from baseline, with the signifi  cance of this change assessed separately for normal and rapid progressors using a mixed-
effects statistical model. (B) The percent CD4     of total T cells in BAL is plotted against the same measurement in small intestinal (jejunal) biopsy cell prep-
arations from RMs with pulmonary lavage examination and small intestinal biopsy within 7 d of each other. The analysis includes 12 plateau-phase 
SIVmac239-infected RMs (red; median pvl   550,000 copies/ml), 12 SIVmac239(     nef)-infected RMs (light blue; median pvl   180 copies/ml), and 15 SIV        
normal control RMs (dark blue). The plot shows a linear regression line with the correlation coeffi  cient and p-value of the correlation indicated in the top 
left corner. (C) PLNs from 11 SIVmac239-infected normal progressors with AIDS and 10 SIV         control RMs were analyzed by fl  ow cytometry for evidence 
of relative CD4      depletion in either the memory or naive compartments. CD3      T cells, including both CD4      and CD8      lineages, were fi  rst separated into 
naive and memory compartments by phenotypic criteria (see Materials and methods), and then the relative fractions of CD4      cells within these compart-
ments were determined. Results are presented as percent CD4      (of total naive or memory T cells). The red lines designate the mean percent CD4     values, 
with signifi  cance of differences between SIV         and  SIV     RMs determined by unpaired   t   test.   2174 DETERMINANTS OF PROGRESSION IN CHRONIC SIV INFECTION | Okoye et al.
  Collectively, these data indicate that BAL CD4      T  EM   cell 
depletion is the most profound T cell population abnormality 
in AIDS (P   <   0.0001), but as severe depletion has already oc-
curred in acute infection, the resulting CD4      T  EM   cell defi  cit 
might not be expected to play a determining role in the much 
later onset of chronic-phase disease. However, as shown in 
  Fig. 3  , CD4      T cell frequencies in BAL initially rebounded 
after acute depletion, but after day 100, they progressively de-
clined in all normal progressors examined (with a mean popu-
lation half-life of    107 d; see legend to  Fig. 3 ).   This observation 
strongly supports the hypothesis that CD4      T  EM   cell depletion 
constitutes a primary mechanism of immunodefi  ciency, with 
overt disease ensuing when the representation of these cells in 
extra-lymphoid eff  ector sites declines below a critical level. At 
the time of AIDS onset in our cohort, the average (  SEM) 
fraction of CD4      T cells within the BAL T cell compartment 
was 0.42   0.08%, a value that provides a substantive estimate 
for this critical threshold. 
  T cell populations in BAL are short-lived and dependent 
on continuous T  EM   cell production and migration 
  To investigate the mechanisms underlying BAL CD4      T  EM   
cell decline, we used short-term BrdU labeling (three doses 
over 24 h) to compare the dynamics of BAL T  EM   cell popula-
tions in clinically stable, chronically SIVmac239-infected RMs 
versus uninfected RMs.   Fig. 4   A shows a typical profi  le of a 
chronically infected RM.   Note that peak labeling exceeds 25% 
of BAL CD4      T cells, occurs 4 d after the last BrdU dose, and 
cell expansion. Importantly, the representation of CD4      T 
cells in BAL closely correlated with that of small intestinal lam-
ina propria, another T  EM   cell  –  populated eff  ector compartment 
(  18  ), suggesting that the BAL compartment was an accurate 
indicator of systemic eff  ector site CD4      T  EM   cell representa-
tion (  Fig. 2 B  ). 
  Decline in the absolute number of circulating total CD4  +   
memory T cells was also highly signifi  cant in both rapid and 
normal progression, albeit less dramatic than the loss of CD4      
T  EM   cells in BAL (  Fig. 2 A  ). In contrast, the numbers of CD4      
naive T cells in blood were not a strong correlate of AIDS as 
they were only variably and modestly diminished in chronic 
AIDS and, as described previously (  15  ), were actually increased 
in rapid progression. Because of this CD4      naive T cell hetero-
geneity, the absolute numbers of total CD4      T cells in blood, 
the standard marker in disease progression in HIV infection (  1  ), 
were signifi  cantly reduced only in the chronically SIV-infected 
RMs, and even in this setting, the extent of this loss was highly 
variable. The numbers of circulating CD8      T cells, both mem-
ory and naive, also varied in overt AIDS but tended to be nor-
mal or elevated (  Fig. 2 A  ). Cross-sectional analysis of the overall 
naive and memory T cell compartments of peripheral LNs 
(PLNs) in AIDS-stage normal progressors versus uninfected 
RMs revealed a statistically signifi  cant decline in CD4      repre-
sentation in the total memory, but not the naive, compartments 
(  Fig. 2 C  ), providing further evidence that systemic CD4      
memory, but not naive, T cell depletion is a uniform T cell 
population correlate of AIDS. 
  Figure 3.     Kinetics of CD4      T cell decline in the lung. BAL cell preparations were stained for CD3 and CD4, and the percent CD4      T cells (of total 
CD3      T cells) was determined by fl  ow cytometry for eight SIVmac239-infected normal progressors that did not receive ART during their course and were 
followed to an AIDS endpoint (note that nearly all BAL T cells are T  EM   cell phenotype [  18  ]). For each RM, the     log 10  (%CD4) per 100 d was determined from 
PID 100 to endpoint (“slope”), and the p-value of the regression line is designated in the top right corner of each profi  le. The pooled     log 10 (%CD4)  per 
100 d plus SEM for all eight RMs was     0.28    0.04 (P   0.0003), which corresponds to an average CD4      T cell population half-life of 107 d (using the 
formula t  1/2     log  10  (0.5)/b, where b is the pooled slope estimate).     JEM VOL. 204, September 3, 2007 
ARTICLE
2175
the peak labeling of CD4      T  EM   cells in chronically infected 
RMs and the subsequent reduction in number of these labeled 
cells were two- to threefold greater than in uninfected RMs 
(  Fig. 4 B  ), indicating a substantial increase in the fraction of 
short-lived cells within the BAL population of infected versus 
uninfected animals. Notably, the peak BrdU labeling and the 
magnitude of the subsequent decay of CD8  +   T  EM   cells in BAL 
were similarly elevated in the infected versus uninfected RMs, 
includes cells that are almost entirely postproliferative (Ki-67    −   ). 
Collectively with previous observations (  15  ), these data indicate 
that a substantial fraction of the BAL CD4      T  EM   cell popula-
tion is replaced daily from recently divided precursors, originat-
ing elsewhere, and emigrating to the lung via the blood. The 
vast majority of labeled cells disappear over the ensuing month, 
which, in the absence of proliferative dilution, is most likely 
due to in situ death (and replacement by nonlabeled cells). Both 
  Figure 4.     T  EM   cell dynamics in the pulmonary airspace. (A) An SIVmac239-infected normal progressor (RM no. 20955: PID 1,125; pvl   69,000 copies/ml) 
was administered three intravenous doses (30 mg/kg) of BrdU over 24 h, and BAL samples were obtained before BrdU administration (day 0) and at 
subsequent intervals for fl  ow cytometric analysis of BrdU incorporation in CD4      T cells. The fi  rst post-BrdU sampling was 14 h after the last BrdU dose 
and is designated day 1. The percentage of total BrdU      cells,  Ki-67        BrdU     cells, and Ki-67      BrdU     cells was determined at each time point. (B) BrdU was 
administered to and BAL samples were collected from four uninfected (control) RMs and four plateau-phase SIVmac239-infected RMs (RM no. 20955, as 
above; no. 21046: PID 1,125; pvl   360,000 copies/ml; no. 21192: PID 456; pvl   240,000 copies/ml; no. 21580: PID 876; pvl   80,000 copies/ml) as de-
scribed in A. The overall percent BrdU      in BAL CD4      and  CD8     T cell populations are shown. Differences in peak and plateau (day 42) labeling were deter-
mined by unpaired   t   test (p-values shown in the top right corner of each profi  le). (C) BrdU was administered to and BAL samples were collected from RM 
numbers 21046 and 20955 three successive times over the course of their SIVmac239 infection: Pre-ART (PID 577; pvls   200,000 and 500,000 copies/ml, 
respectively; percent CD4     in BAL   0.41 and 1.7%, respectively); on stable ART (PID 764: pvls   280 and      30 copies/ml, respectively; percent CD4     
in BAL   19.7 and 9.6%, respectively), and 7 mo after ART discontinuation (PID 1,125; pvls   360,000 and 69,000, respectively; percent CD4     in BAL: 
0.43 and 1.4%, respectively). The overall percent BrdU      of BAL CD4      and  CD8     T cell populations is shown. (D) CCR5 expression was determined by fl  ow 
cytometry on the BrdU-labeled CD4      and  CD8     T cells of the SIVmac239-infected RMs described in B. The fraction of BrdU      CD4     and  CD8     T  cells 
expressing CCR5 is shown over time (*, insuffi  cient cells for analysis). A random slope statistical model was used to determine the stability of CCR5 
expression over time for the labeled CD4      T cells. This analysis showed that (a) none of the individual slopes (loss of CCR5-expressing, BrdU     CD4      T  cells 
in BAL over time) was statistically signifi  cant after adjusting for multiple comparisons, and (b) the overall slope (average loss per day among four animals) 
was not statistically signifi   cant.   2176 DETERMINANTS OF PROGRESSION IN CHRONIC SIV INFECTION | Okoye et al.
CD4      T  EM   cells in BAL was occurring, its contribution to the 
decreased lifespan of these cells in infected RMs must be quite 
small relative to their overall rate of loss. 
  Progressive loss of CD4      T  CM   cell homeostasis and T  EM   cell 
production in chronic infection 
  The above data indicate that during chronic infection, the di-
minished BAL CD4      T  EM   cell population is largely comprised 
of relatively short-lived cells that are highly dependent on new 
memory cell production and emigration for homeostasis, 
a fi  nding suggesting that CD4      memory T cell production 
dynamics might play a role in the progressive decline of BAL 
CD4  +   T  EM   cells in chronically infected RMs. As shown in 
  Fig. 5 A  , the proliferating (Ki-67  +  ) fraction of CD4      memory 
T cells in the blood may indeed fall during chronic infection 
(RMs nos. 20197 and 20408), but this decline is not uniform, 
coming very late in some RMs (no. 21064) and not at all in 
others (no. 20502).   However, systemic production is more 
and eff  ective ART normalized the BrdU labeling profi  les of 
both CD4  +   and CD8      T  EM   cells (  Fig. 4 C  ). As viral cytopatho-
genicity would aff  ect CD4      T  EM   cells much more than CD8      
T  EM   cells, the essentially identical dynamics and ART response 
of the two subsets strongly suggest that the accelerated turnover 
of BAL T  EM   cells primarily refl  ects immune activation-medi-
ated apoptosis, rather than viral-mediated destruction. To fur-
ther assess whether direct coreceptor-targeted, viral-mediated 
cell destruction contributes to the rapid decline of BrdU-
labeled CD4      T  EM   cells in BAL, we compared the frequency at 
which these cells expressed CCR5 over time to that of labeled 
CD8      T  EM   cells (  Fig. 4 D  ). Direct viral-mediated killing would 
be expected to preferentially target the CCR5      component of 
CD4      T  EM   cells, resulting in decreasing frequencies of CCR5  +   
cells over time among labeled CD4      T  EM   cells, but not CD8  +   
T  EM   cells. Importantly, CCR5 expression was largely stable in 
the labeled CD4      T  EM   cells in the BAL of infected RMs, fur-
ther indicating that if direct viral killing of recently divided 
  Figure 5.     Proliferating CD4      and CD8      memory T cell dynamics in the blood. (A) The fraction of proliferating cells (Ki-67     ) is shown over the 
course of chronic/progressive SIVmac239 infection in four representative RMs that did not receive ART and were followed to an AIDS endpoint. (B) The 
absolute number of proliferating (Ki-67    )  CD4     and  CD8     memory T cells is shown for the entire course of SIVmac239 infection in the same group of 
untreated normal progressors described in Fig. 3, and for comparison, a group of SIV(     nef)-infected nonprogressors followed for 600 d. The pooled 
    log 10 (%Ki-67     memory T cells) per 100 d (      SEM) from PID 100 to endpoint (progressors) or PID 100  –  600 (nonprogressors) is shown for each analysis, 
along with the p-value delineating the statistical signifi  cance of these pooled slopes.     JEM VOL. 204, September 3, 2007 
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In attenuated SIVmac239(     nef  ) infection, the numbers of pro-
liferating CD4      memory T cells showed a very slight decline 
over 600 d that did not quite achieve statistical signifi  cance. 
  The overall memory T cell population in blood is com-
posed of three phenotypically distinguishable components:T  CM   
cells, transitional T  EM   cells, and fully diff  erentiated T  EM   cells, 
with both T  EM   cell subsets expressing CCR5 and being eff  ec-
tor site directed (  Fig. 6 A  ) (  18  ).   On average, approximately one 
third of the proliferating CD4      memory T cell   compartment 
directly related to the overall number of proliferating cells, and 
we therefore followed the absolute number of proliferating 
total memory T cells in the blood throughout the course of 
infection in eight untreated SIVmac239-infected normal pro-
gressors and in four RMs with attenuated (clinically non-
progressive) SIVmac239(     nef) infection (  Fig. 5 B  ). This analysis 
demonstrated a highly signifi  cant progressive loss of proliferat-
ing CD4      memory T cells in the normal progressors, but 
not of proliferating CD8      memory T cells in the same RM. 
  Figure 6.     Effect of infection on CD4      T  EM   cell differentiation from proliferating T  CM   cell precursors. (A) Schema of memory T cell differentia-
tion in RMs (  18  ). (B) The top profi  les show CD4      T cells from one RM with attenuated SIVmac239(     nef) infection (PID 387; pvl   5,200 copies/ml) and 
one with progressive SIVmac239 infection (PID 579; pvl   3,800,000 copies/ml), indicating the gating of proliferating (Ki-67    )  CD4     memory T cells. The 
bottom profi  les show the representation of T  CM   cells  (CD28   ;  CCR5       ) versus total T  EM   cells (including CD28    ,  CCR5     transitional  T EM   cells, and CD28       /
CCR5  dim    mature T  EM   cells) within the proliferating CD4      memory compartment. (C) The fi  gure shows cross-sectional analysis of the fractional represen-
tation of total T  EM   cells (as in A) in 10 SIV         RMs, 7 RMs with early plateau-phase SIVmac239 infection (PID 105; median pvl   5,300,000 copies/ml), 
8 RMs with late plateau-phase SIVmac239 infection (PID 533  –  878; median pvl   660,000 copies/ml), and 12 RMs with controlled SIV infection: 9 infected 
with SIVmac239(    nef)  (PID  154 – 390;  pvls    400 copies/ml) and 3 spontaneous controllers of SIVmac239 (PID 105  –  147: pvls       4,000 copies/ml). Differ-
ences were assessed by unpaired   t   test. (D) The profi  les show the fractional representation of T  EM   cells among proliferating (Ki-67    )  CD4     memory T cells 
from PLNs from an RM 5 d before SIVmac239 infection, at PID 150 (immediately before ART; pvl   4,400,000 copies/ml), and at 4 (pvl   180,000) and 8 d 
(pvl   87,000) after ART initiation. (E) The profi  les show the fractional representation of T  EM   cells among proliferating (Ki-67    )  CD4     memory T cells from 
the blood of an SIVmac239-infected RM at PID 105 (immediately before ART; pvl   3,000,000 copies/ml) and days 4 (pvl   220,000 copies/ml), 10 (pvl   
170,000 copies/ml), and 17 (pvl   24,000 copies/ml) after ART. The arrow indicates the development of a fully mature CD4      T EM   cell  population.   2178 DETERMINANTS OF PROGRESSION IN CHRONIC SIV INFECTION | Okoye et al.
direct SIV infection of the former subset. True CD4      T  CM   cells 
lack detectable surface expression of the CCR5 coreceptor and 
thus would be predicted to be protected from infection; how-
ever, previous work has suggested that detectable surface ex-
pression of CCR5 may not be necessary for a CD4      memory 
cell to be infected (  30  ). Indeed, as shown in   Fig. 7 B  , SIV DNA 
was readily detectable by real-time PCR in sorted, precisely 
defi  ned (CCR7      CCR5    −   ) CD4      T  CM   cells from both early 
plateau-phase RMs and normal progressors with AIDS. SIV 
DNA was either absent from CD8      T  CM   cells or found at sig-
nifi  cantly lower levels. In normal progressors with AIDS, SIV 
DNA levels in CD4      T  CM   cells were     15% of those detected 
in CD4  +   (CCR5  +  ) transitional T  EM   cells, consistent with a less 
effi   cient infection of the former subset. Interestingly, the SIV 
DNA content of CD4      T  CM   cells from RMs with early 
plateau-phase SIVmac239 infection was signifi  cantly (threefold) 
higher than in the RMs with end-stage infection, whereas SIV 
content of CD4      T  EM   cells was not diff  erent between these 
RM groups. This diff  erence in CD4      T  CM   cell infection was 
not related to overall SIV replication, as pvls were not signifi  -
cantly diff  erent in the two groups. However, CD4      T  CM   cell 
proliferation (%Ki-67) was signifi  cantly higher in the early pla-
teau-phase RMs, suggesting that CD4      T  CM   cell infection can 
be driven by high activation/proliferation to levels approaching 
those of CD4  +   T  EM   cells with overt CCR5 expression. 
  To determine the pathobiologic signifi  cance of this CD4  +   
T  CM   cell infection, we compared the dynamics of (CCR7      
CCR5    −   ) CD4  +   and CD8  +   T  CM   cells during acute SIVmac239 
infection and through early plateau-phase ART administration. 
As illustrated in two representative RMs (  Fig. 7 C  ), absolute 
numbers of CD4      T  CM   cells in the blood decline     70% in 
acute infection, concomitant with a 98  –  99% depletion of BAL 
CD4      T  EM   cells in the same RM (not depicted). The observa-
tions that (a) CD8      T  CM   cells show only a modest, very tran-
sient depletion during this period (  Fig. 7 C  ), and (b) that CD4 
representation in the PLN T  CM   cell compartment declines to a 
similar degree as blood CD4      T  CM   cell counts (not depicted) 
suggest that the CD4      T  CM   cell depletion primarily refl  ects 
  direct viral-mediated killing of CD4      T  CM   cells, rather than 
a redistribution eff  ect. Increased proliferation rates stabilize 
  circulating CD4      T  CM   cell numbers in plateau-phase infection, 
but continued viral-mediated killing is demonstrated by the 
observation that ART administration in plateau-phase results 
in a very rapid and lineage-specifi  c increase in CD4      T  CM   cell 
counts and in the fraction of proliferating CD4      T  CM   cells (  Fig. 
7 C  ). A similar increase in proliferation with ART is observed 
in PLNs (  Fig. 7 D  ), suggesting that ART is acting immediately 
to relieve direct viral-mediated destruction of rapidly proliferat-
ing CD4      T  CM   cells. Thus, despite undetectable CCR5 ex-
pression, CD4      T  CM   cells, particularly proliferating cells, are 
SIV infectable and directly killed by virus. 
    DISCUSSION   
  In the past few years, it has been widely documented that 
  primary infection with pathogenic, CCR5-tropic HIV and 
SIV, though generally asymptomatic, has extensive immunologic 
in the blood of uninfected RMs is comprised of CCR5-
  expressing T  EM   cell subsets; however, in SIV-infected RMs, 
this fraction is highly dependent on the degree of pathogenesis. 
In attenuated SIV infections or wild-type SIV infections in RMs 
with spontaneous control, we observed a signifi  cant increase 
in the T  EM   cell fraction of proliferating CD4      memory cells in 
comparison to uninfected RMs, consistent with the expected 
eff  ect of chronic immune activation in driving eff  ector diff  er-
entiation (  28  ). In contrast, the T  EM   cell fraction was reduced 
approximately fourfold throughout pathogenic infection (  Fig. 
6, B and C  ). CD4      T  EM   cells (predominantly transitional type) 
were also reduced in PLNs in chronic SIVmac239 infection 
(  Fig. 6 D  ), indicating that the reduction in proliferating CD4  +   
T  EM   cells in the blood was not due to retention in secondary 
lymphoid tissues. Moreover, eff  ective ART results in an im-
mediate burst of proliferating or recently divided transitional 
CD4      T  EM   cells in the PLNs and blood (  Fig. 6, D and E  ), fol-
lowed later by mature CD4      T  EM   cells (  Fig. 6 E  ), suggesting 
that although rapid CD4      T  EM   cell generation and diff  erenti-
ation is continuously driven by infection-associated immune 
activation, these new T  EM   cells and/or their immediate pre-
cursors are being destroyed almost as rapidly by direct virus-
  mediated cytopathogenicity. Importantly, the effi   ciency of this 
depletion does not appear to change over the course of chronic 
infection (compare early vs. late plateau-phase in   Fig. 6 C  ), 
suggesting that this eff  ect acts as a relatively constant impedi-
ment to CD4      T  EM   cell production that does not, by itself, 
explain the progressive decline in CD4 T  EM   cell populations 
in extra-lymphoid sites. 
  CD4      T  CM   cells are susceptible to immune activation, 
infection, and direct virus-mediated destruction 
  Collectively, these data (an overall decrease in proliferating 
CD4      memory T cells and stable rates of CD4      T  EM   cell dif-
ferentiation) lead to the conclusion that the progressive decline 
in CD4      T  EM   cell production in chronic SIV infection origi-
nates from a progressive decline in proliferating CD4      T  CM   
cells caused by a decreasing CD4      T  CM   cell proliferation rate 
and/or a progressive decline in overall CD4      T  CM   cell numbers 
(  Fig. 2, A and C  ). Factors contributing to loss of CD4      T  CM   
cell homeostasis would therefore constitute primary determi-
nants of immunodefi  ciency development. One such factor 
might be persistent immune activation with its previously dem-
onstrated eff  ect of increasing T cell proliferation and turnover 
(  12, 34  ). Indeed, we found that in the chronically SIV-infected 
RMs studied here, CD4      T  CM   cells manifest a higher fraction 
of proliferating cells with rapid turnover (  Fig. 7 A  ), potentially 
leading to proliferative senescence and/or inadequate renewal 
of long-lived cells (  11, 29  ).   However, interpreting these factors 
as contributing to the progressive failure of CD4      T  CM   cell 
  homeostasis is not straightforward because CD8      T  CM   cell 
  populations, which are relatively stable during chronic infec-
tion, manifest similar, although somewhat less severe, changes 
in proliferation and turnover in infected RMs (  Fig. 7 A  ). 
  A factor with perhaps greater potential to diff  erentially 
aff  ect CD4      T  CM   cell versus CD8      T  CM   cell homeostasis is JEM VOL. 204, September 3, 2007 
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  Figure 7.     Effect of infection on CD4      T  CM   cell homeostasis. (A) BrdU was administered to and blood samples were collected from fi  ve uninfected 
(control) RMs and fi  ve late plateau-phase SIVmac239-infected RMs (PID 466  –  1125; median pvl   240,000 copies/ml) as described in Fig. 4. The overall 
percent BrdU      was determined by fl  ow cytometry on CD95    ,  CD28    , and CCR5         T CM   cells, both CD4      and  CD8    , at the time points shown. Data from all 
10 RMs are included in the CD4      T CM   cell analysis. As one SIV      RM had insuffi  cient numbers of evaluable CD8      T CM   cells, only four SIV      RMs are included 
in the CD8     T  CM  cell analysis. (B) CD4      and  CD8     T CM   cells  (CD95   ,  CD28   ,  CCR5      ,  CCR7    ) and CD4      transitional  T EM   cells  (CD95   ,  CD28   ,  CCR5   )  were 
sorted from splenic mononuclear cell preparations taken at necropsy from eight SIVmac239-infected RMs (four with early [asymptomatic] plateau-phase 
infection [PID 78  –  85] and four with chronic-onset AIDS [PID 372, 483, 554, and 1,157]) and assessed for SIV DNA content. The average pvl and percent 
Ki-67     within the splenic CD4      T CM   cells from each RM group are also shown. The signifi  cance of differences was assessed by unpaired   t   test. (C) The 
absolute number and fractional proliferation (percent Ki-67     ) of highly defi  ned CD4      and  CD8     T CM   cells in the blood are shown for two representative 
SIVmac239-infected RMs through early plateau phase and after ART. The median pre-ART plateau-phase pvls in both of these RMs were    4,000,000 
copies/ml, with ART decreasing these values to 22,000 and 50,000 copies/ml for RM numbers 23788 and 23892, respectively. (D) Three SIVmac239-
  infected RMs were treated with ART at PID 132 (no. 23186) or PID 153 (nos. 23208 and 23186) with PLN biopsy immediately before and 4 and 8 d after 
ART (mean pre-ART and post-ART days 4 and 8; pvls   6,000,000, 237,000, and 56,000 copies/ml, respectively). The proliferating fraction (percent Ki-67    ) 
of CD4      and CD8      T CM   cells from each of these PLN biopsies is shown (with differences between post-ART change in percent Ki-67     of CD4      and  CD8    
T  CM   cells evaluated by paired   t   test).   2180 DETERMINANTS OF PROGRESSION IN CHRONIC SIV INFECTION | Okoye et al.
disease onset in chronic, progressive infection. The latter obser-
vation supports the existence of a threshold in eff  ector site 
CD4      T  EM   cell representation below which the SIV-infected 
host becomes highly susceptible to opportunistic infection. This 
interpretation is even more compelling given our previous 
  observation that rapid progression to AIDS was associated with 
cessation of CD4      T  EM   cell production and infl  ux into extra-
lymphoid sites (  15  ), and the fact that the opportunistic infec-
tions found in our AIDS-affl   icted RMs (CMV, cryptosporidia, 
pneumocystis) most commonly developed in such eff  ector sites 
(unpublished data). We do not discount the possibility that 
functional or repertoire alterations of CD4      or CD8      memory 
T cells or abnormalities in accessory non  –  T cells might also 
contribute to immune defi  ciency, but would postulate that 
such qualitative abnormalities would serve to facilitate immune 
defi  ciency only in the setting of profound CD4      T  EM   cell 
  depletion, perhaps aff  ecting the threshold of CD4      T  EM   cell 
depletion at which overt immune defi  ciency ensues. 
  BrdU labeling of chronically SIVmac239-infected RMs 
was then used to explore the dynamics of pulmonary CD4      
T  EM   cells and provide insights into the mechanisms underlying 
their progressive decline. We found that this population is 
largely comprised of short-lived nonreplicating cells and conse-
quently is highly dependent on the continuous emigration of 
recently divided T  EM   cells from the blood. Notably, pulmonary 
CD8  +   T  EM   cells manifested similar kinetic properties suggesting 
that (a) the short life span of the CD4      T  EM   cells in BAL was 
not attributable to direct viral-mediated destruction, but rather 
was likely a result of chronic immune activation (  12, 34  ), and 
(b) that the progressive decline in CD4      T  EM   cells was deter-
mined elsewhere, probably by factors controlling the supply of 
these cells to extra-lymphoid eff  ector sites. In keeping with the 
latter hypothesis, we found that absolute numbers of proliferat-
ing or recently divided CD4     , but not CD8     , memory T cells 
in the blood progressively declined in chronic SIVmac239 
  infection (but not in attenuated SIVmac239(     nef) infection). 
The fraction of these proliferating or recently divided CD4      
memory cells exhibiting T  EM   cell diff  erentiation (i.e., the 
  immediate precursors to extra-lymphoid site T  EM   cells) was 
considerably diminished in progressive infection by direct 
virus-mediated destruction (Fig. 6), but, importantly, this 
fraction did not appear to change over the course of chronic 
infection. Collectively, these fi  ndings strongly suggested that 
a progressive, systemic decline of the proliferating CD4      T  CM   
cell compartment resulted in a progressively diminished sub-
strate for CD4      T  EM   cell diff  erentiation. This in turn reduced 
CD4  +   T  EM   cell production and eff  ector site emigration, leading 
to decreasing eff  ector site CD4      T  EM   cell populations and ulti-
mately (when the latter fell below threshold) to AIDS (  Fig. 8  ).   
  In contrast to a previous report (  33  ), CD4      naive T cell 
populations were not generally depleted in the progressive 
infections studied here, as measured by both the absolute 
numbers of CD4      naive T cells in the blood and the relative 
representation of CD4      versus CD8      naive T cells in PLNs. 
Thus, at least in the SIVmac239 AIDS model, CD4  +   T  CM   cell 
homeostasis can fail in the face of a relatively intact CD4      naive 
consequences (  12, 20, 21, 23  ). The high viral replication of 
primary infection rapidly destroys the bulk of the body  ’  s CD4      
memory T cell population, particularly CD4      T  EM   cells in 
mucosal extra-lymphoid eff  ector sites (  15, 19, 30, 31  ), and also 
initiates a state of persistent immune activation that has been 
widely implicated in immunodefi  ciency development (  10  –  12, 
21, 24, 25, 32  ). However, CD4      memory T cells are not equally 
susceptible to this acute destruction, and in SIV-infected RMs, 
we have previously demonstrated that spared populations (pre-
dominantly CCR5    −    T  CM   cells) undergo a substantial increase 
in proliferative activity that sustains these populations and pro-
vides suffi   cient T  EM   cell production and infl  ux into eff  ector 
sites to maintain clinical immune competence ( 15  ).  Chronically 
SIV-infected RMs and HIV-infected humans establish a new 
immunologic steady-state associated with high CD4      memory 
T cell turnover and characterized by a substantially diminished 
CD4      T  EM   cell compartment (  11, 12, 15, 22, 33  –  35  ). Ulti-
mately, this steady-state is degraded and immunodefi  ciency 
ensues, but the quantitative changes in rate-limiting parameters 
that underlie this degradation in the course of chronic infec-
tion, as well as the mechanisms responsible for these changes, 
have not been clearly defi  ned. 
  Here, we systematically assessed the relationship between 
potential determinants of pathogenesis and AIDS onset in 
chronically SIVmac239-infected RMs. Although it remains 
possible that there are multiple paths to AIDS in this model, 
our data strongly support a common   “  primary  ”   pathway and 
suggest a surprisingly cohesive mechanistic sequence. Two 
important virologic observations guided our investigation: fi  rst, 
that within the range of plateau-phase pvls manifested by 
SIVmac239-infected normal progressors, these pvls did not 
strongly predict time to disease, and second, that the plateau-
phase pvls in these normal progressors remained steady through 
to disease onset. Regarding the fi  rst observation, it is clear that 
in HIV infection, plateau-phase pvls delineate broad groups of 
individuals with diff  erent rates of disease progression (  3  ), but 
the predictive value of viral replication is limited (  36  ), and host 
factors (such as the degree of immune activation) have been 
demonstrated to exert a major infl  uence on prognosis (  24  –  26  ). 
Similarly, although SIVmac239 replication rates predict rapid 
versus normal versus slow progression in RMs (  15, 37  –  39  ), 
they did not account for the range of disease-free survival times 
exhibited by normal progressors in our study, strongly suggest-
ing that in these RMs, host factors are the primary determi-
nants of chronic-phase disease. The stability of plateau-phase 
pvls through disease onset in the normal progressors studied 
here further supports this hypothesis, suggesting that a dimin-
ishing ability of host immunity to control viral replication or 
the emergence of more effi   ciently replicating viral variants were 
unlikely to be the critical processes leading to AIDS. 
  We next established that BAL CD4      T  EM   cell depletion 
was the strongest correlate of disease. Most importantly, having 
shown that changes in the CD4      T  EM   cell representation in 
BAL closely paralleled changes in the small intestine, we dem-
onstrated a highly consistent, gradual progression in BAL CD4      
T  EM   cell depletion from the initial post-acute steady-state to JEM VOL. 204, September 3, 2007 
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CD4      T cells can be visualized by in situ hybridization in the 
extra-lymphoid eff  ector sites of these RMs (unpublished data), 
we found no functional evidence that this infection further 
cell compartment. Moreover, studies of thymectomized RMs 
infected with CXCR4-tropic (naive CD4  +   T cell  –  depleting) 
SIVmac155T3 (  15  ) have demonstrated that CD4      T  CM   cell 
homeostasis can be maintained long-term in the complete ab-
sence of a CD4  +   naive T cell compartment (unpublished data). 
These data suggest that although naive CD4      T cells are nomi-
nally the precursors for CD4      T  CM   cells, the naive population 
is not a major determinant of CD4      T  CM   cell homeostasis in 
chronic SIV infection. 
  What then is responsible for the progressive decline in 
CD4      T  CM   cell production? BrdU labeling studies demon-
strate that both CD4      and CD8      T  CM   cell populations mani-
fest a sustained increase in cell turnover in chronic SIV 
infection, consistent with an immune activation eff  ect (  12  ) and 
potentially setting up these populations for slow proliferative 
senescence (  10, 29  ). This increase in turnover, measured in the 
blood, is slightly more pronounced for CD4      T  CM   cells than 
CD8      T  CM   cells, but this diff  erence, by itself, seems unlikely to 
explain the gross disparity in CD4      versus CD8  +   T  CM   cell sta-
bility. However, we also demonstrate that, as opposed to CD8  +   
T  CM   cells, CD4      T  CM   cells are readily infected by CCR5-tropic 
SIV in vivo (albeit less effi   ciently than CCR5      T  EM   cells), 
and are, in fact, continuously destroyed in vivo by a direct, 
virus replication-dependent mechanism (as revealed by their 
immediate post-ART kinetics). This killing clearly targets 
proliferating CD4      T  CM   cells in LNs (  Fig. 7 D  ) before 
their emigration into the blood, therefore making their loss 
  “    invisible  ”   to BrdU analysis in the blood (indicating that total 
CD4      T  CM   cell loss rates are underestimated by this analysis). 
This ongoing, virus-mediated CD4      T  CM   cell destruction, espe-
cially of the proliferating compartment in LNs, would clearly 
put CD4      T  CM   cell homeostasis under more stress than its 
CD8      counterpart, potentially leading to imbalance in pro-
duction versus destruction in the former, but not the latter, 
subset. Other factors could also contribute to a CD4      T  CM   
cell homeostatic imbalance, including progressive damage to 
microenvironments supportive of T  CM   cell homeostasis (  9, 40  ) 
and progressive loss of regeneration capacity due to acceler-
ated   “  aging-like  ”   disorganization of the immune system (  12  ). 
Even though such factors would potentially aff  ect both CD4      
and CD8      subsets, the eff  ects need not be equal (  9, 21  ). 
  Our data defi  ne a complex interplay between cell destruc-
tion by direct infection on the one hand and immune activa-
tion on the other in AIDS pathogenesis. With regard to the 
CD4      T  EM   cell compartment, direct viral-mediated destruc-
tion (either productive infection or virus-triggered apoptosis) is 
almost certainly responsible for the initial depletion of extra-
lymphoid site CD4  +   T  EM   cells in acute infection (  15, 30, 31  ) 
and for the continuous elimination of     70% of the diff  erenti-
ating CD4      T  EM   cells arising from T  CM   cell precursors in PLNs 
and blood (this study). In chronic infection, however, the fate 
of extra-lymphoid site T  EM   cells, both CD4      and CD8     , ap-
peared to be governed by immune activation with a consider-
ably larger proportion of cells of both subsets possessing shorter 
life spans (due to activation-induced apoptosis) than those 
  observed in uninfected controls. Interestingly, although infected 
  Figure 8.     The descent to AIDS: decreasing numbers and chang-
ing proportions of CD4      memory T cell populations in chronic 
SIVmac239 infection. The fi  gure schematically illustrates the progres-
sive decline in the regeneration of long-lived T  CM   cells and, consequently, 
in the production of short-lived, tissue-seeking T  EM   cells. The T  CM   cell 
compartment consists of T  CM   cells in secondary lymphoid tissues 
and recirculating in the blood. The T  EM   cell compartment represents 
cells resident in extra-lymphoid effector sites. Estimated populations 
include: (a) recently divided (Ki-67     ) cells (cells that have been in 
S-phase of the cell cycle in the preceding week), (b) short-lived 
cells (Ki-67         cells destined to die or resume division in  2 – 3  wk), 
(c) long-lived cells (Ki-67         cells destined to live  3 wk without cell divi-
sion), and (d) dying cells (either apoptosis or direct viral destruction). 
The left to right horizontal arrows indicate the relative rate of produc-
tion and effector site emigration of T  EM   cells. The semicircular arrow 
adjacent to the T  CM   cell compartment indicates the relative effi  ciency of 
T  CM   cell regeneration (note that proliferating T  CM   cells provide the sub-
strate for both T  CM   cell regeneration and T  EM   cell production). (A) Pre-
infection baseline. Both T  CM   and  T EM   cell compartments include relatively 
large proportions of long-lived cells. (B) Asymptomatic chronic phase  —
  mid-course. Both compartments have experienced dramatic acute-
phase depletion (T  EM     T  CM  ) and have established a quasi-stable 
steady-state with substantially reduced cell numbers, especially of 
long-lived cells, and increased proliferation and death rates. Both T  CM  
cell regeneration and T  EM   cell production are reduced severalfold from 
baseline, despite the increased proportion of proliferating T  CM   cells,  but 
this fractional increase in a reduced compartment is still suffi  cient to 
maintain predominantly short-lived T  EM   cell populations above the im-
mune defi  ciency threshold. (C) End-stage chronic phase  —  AIDS onset. 
Progressive decline in the T  CM   cell compartment has reduced T  EM   cell 
production and delivery to effector sites below the minimum necessary 
to maintain T  EM   cell populations above threshold, leaving these sites 
increasingly susceptible to opportunistic infection.     2182 DETERMINANTS OF PROGRESSION IN CHRONIC SIV INFECTION | Okoye et al.
infect CD4  +   T  CM   cells as well [  47, 48  ]), the occurrence of 
generalized immune activation, and in particular, the eff  ect 
of this immune activation on the turnover and diff  erentiation 
of CD4  +   memory T cells (including T  CM   cells) and on prog-
nosis (  24  –  26, 34, 49, 50  ). Moreover, the clinical manifestations 
of AIDS in SIVmac-infected RMs are highly analogous to 
those of HIV-infected humans (  27, 51, 52  ), consistent with a 
similar immune defi  cit. The generally lower viral replication 
rates of HIV-infected people deplete the CD4      T  EM   cell com-
partment less completely than in SIV-infected RMs, and the 
immune activation-driven production of CD4      T  EM   cells is 
clearly better able to initially keep up with direct and indirect 
destruction of these T cells, as both the fraction of memory T 
cells among total CD4      T cells and the fraction of CCR5      
CD4      T  EM   cells among these memory cells in the blood are 
typically normal or elevated in HIV infection (  35, 50, 53  ). 
However, although these diff   erences may allow post-acute 
phase HIV-infected subjects to maintain their CD4      T  EM   cell 
tissue compartments above the threshold for clinical immuno-
defi  ciency for a longer period of time as compared with SIV-
infected RMs, the progressive loss of total CD4      T cell counts 
in the blood that is the hallmark of HIV infection (  1  ), and the 
extensive tissue depletion of CD4      T cells reported at AIDS 
(  54, 55  ), clearly indicate that the ability of infected humans to 
maintain circulating CD4      T  CM   cells and their T  EM   cell prog-
eny declines with time, just as described herein in SIV-infected 
RMs. Whether in HIV infection a parallel depletion of CD4      
naive T cells is critical for the decline of CD4      T  CM   cells, or 
is only a correlate of the longer time to AIDS, is an open 
question. Thus, although the extent and/or tempo of CD4      
memory T cell depletion and viral replication are exaggerated 
in SIV infection compared with HIV infection, we believe the 
evidence strongly suggests that the fundamental pathogenetic 
processes are similar in these two situations. 
  One of the principal enigmas of AIDS pathogenesis, perti-
nent to both the human disease and the RM model, has been 
the paradoxical combination of the continuous (often high 
level) replication of pathogenic virus with long periods of 
clinical   “  latency  ”   and delayed, but catastrophic, disease. Our 
data suggest that this paradox results from a dual nature of 
CCR5-tropic HIV/SIV infection: an effi   cient, highly destruc-
tive infection of easily replaceable CD4      T  EM   cells, and a less 
effi   cient/more selective infection and much slower net de-
struction of precursor CD4      T  CM   cells. It is the diff  erential 
impact of HIV/SIV infection on the CD4      T  CM   and T  EM   cell 
compartments that probably determines the typical pattern of 
chronic AIDS. When the T  CM   cell compartment remains in-
tact (e.g., infection of natural hosts), the infection is nonpatho-
genic; when both compartments are effi   ciently targeted (e.g., 
dual-tropic SHIV infection), disease onset is rapid. What may 
be most crucial for understanding the pathogenesis of typical 
chronic AIDS is that although the exquisite susceptibility of 
the CD4      T  EM   cell compartment to infection results in the 
most dramatic changes to the immune system, it is most likely 
the more covert dynamics of the CD4      T  CM   cell compartment 
that dictate the tempo of disease progression. If these concepts 
shortened the already brief life span of most CD4      T  EM   cells. 
However, the initial viral-mediated depletion and the immune 
activation-mediated shortening in the average life span of 
extra-lymphoid site CD4      T  EM   cells render this population 
highly dependent on a continuous infl  ux of new cells that are 
derived from the proliferation and diff  erentiation of T  CM   cells. 
Immune activation drives this CD4      T  CM   cell proliferation and 
diff  erentiation, but at the same time it appears to increase the 
susceptibility of these cells to infection and destruction, reduc-
ing their steady-state production. Persistent immune activation 
is also thought to be responsible for the microenvironmental 
destruction and aging-like disorganization of the immune sys-
tem mentioned above (  12  ), and these indirect processes likely 
combine with the direct viral eff  ects to destabilize CD4      T  CM   
cell homeostasis, resulting in the slow, progressive decline of 
this precursor population. 
  Our model suggests that CD4      T  CM   cell decline may   “  set 
the clock  ”   in regard to the timing of AIDS onset in RMs and 
therefore predicts that protection of CD4      T  CM   cell homeo-
stasis may be the key to preventing AIDS, a notion supported 
by the recently reported positive correlation between the num-
bers of circulating CD4      CD28      T cells (predominantly T  CM   
cells) with long-term survival in vaccinated SIVmac-challenged 
RMs that fail to control viremia (  41  ). It is also noteworthy that 
in the natural apathogenic SIV infections of African mon-
keys, viral loads are as high or higher than in pathogenic infec-
tions of   humans and RMs and initial extra-lymphoid CD4      
T  EM   cell depletion is as extensive, but in the vast majority of 
these infections, CD4  +   memory T cell populations in the blood 
and LNs are maintained and CD4      T  EM   cell depletion is not 
progressive (references   42  –  46   and Silvestri, G., personal com-
munication). Although the mechanisms underlying the lack of 
clinical progression in these highly active infections are likely 
complex and multi-factorial, the fact that preservation of the 
CD4      T  CM   cell compartment is associated with maintenance 
of a diminished, but stable, CD4      T  EM   cell compartment sug-
gests that in these animals, the CD4      T cell system may be able 
to tolerate the consequences of continuous viral replication 
  because a preserved CD4      T  CM   cell compartment can stably 
maintain CD4      T  EM   cell populations at supra-threshold levels. 
Notably, these infections lack the chronic immune activation 
response that characterizes pathogenic infection (  42  –  46  ), in 
keeping with our above described hypothesis that chronic 
immune activation undermines CD4      T  CM   cell stability. 
  Progression of typical SIVmac239 infection to AIDS (e.g., 
normal progression with AIDS onset at 1.5  –  2 yr after infec-
tion) is approximately fi  vefold accelerated relative to HIV in-
fection, and the plateau-phase pvls in this model are     10-fold 
higher (  3  ), raising the question of whether the mechanisms 
proposed here for RMs apply to human infection. In arguing 
that this is indeed likely to be the case, we would submit that 
the crucial mechanisms that we have identifi  ed in SIVmac-
  infected RMs as driving disease progression have all been docu-
mented in human infection, including selective viral targeting 
of CCR5  +   CD4  +   T  EM   cells and rapid destruction of this com-
partment in acute infection (  22, 35  ) (but with the ability to JEM VOL. 204, September 3, 2007 
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from the phenotypically diverse memory population that is predominantly 
CD95  high   and displays one or more of the following   “  non-naive  ”   pheno-
typic features: CD28    −   , CCR7    −   , CCR5     ,      7-integrin  bright  , or      7-integrin    −  /dim  . 
All analyses included at least two of these markers (usually CD28 vs. CD95) 
for memory subset discrimination. The T  CM   and T  EM   cell components 
of the memory subset in the blood and LNs were delineated based on 
the phenotypic criteria shown in   Fig. 6 A  , with T  EM   referring to the 
combination of transitional and fully diff  erentiated T  EM   cells. As we have 
shown that T cells in eff  ector sites such as BAL and jejunal lamina propria 
are almost exclusively of the T  EM   cell phenotype (  18  ), CD4      and CD8      
T cells from these sites are generally referred to as T  EM   cells. For deter-
mination of CD4 representation within the naive versus memory compart-
ments of LNs, CD4 naive and memory and CD8 naive and memory subsets 
were individually delineated, and Boolean gating was used to create a total 
naive cell and a total memory cell gate from which the percent CD4 
was determined. 
  mAbs.     mAbs L200 (CD4; AmCyan, APC-Cy7), SP34-2 (CD3; PerCP-
Cy5.5), SK1 (CD8     ; APC-Cy7, PerCP-Cy5.5, PE-Cy7; unconjugated), 
CD28.2 (CD28; PE, PerCP-Cy5.5), B56 (Ki-67; FITC, PE), B44 (anti-BrdU; 
FITC; APC), DX2 (CD95; PE, APC, PE-Cy7), 3A9 (CCR5; PE, APC), 
and FIB504 (     7-integrin, PE, PE-Cy7) were obtained from BD Biosciences. 
mAb 2ST8.5h7 (CD8     ; PE, PE-Cy7), CD28.2 (PE-Texas Red), and strep-
tavidin  –  PE-Cy7 were obtained from Beckman Coulter. FN-18 (CD3) was 
produced and purifi  ed in house and conjugated to Pacifi  c Blue or Alexa 700 
using a conjugation kit from Invitrogen. mAb 150503 (anti-CCR7) was pur-
chased as purifi  ed immunoglobulin from R  &  D Systems, conjugated to biotin 
using a Pierce Chemical Co. biotinylation kit, and visualized with streptavidin  – 
Pacifi  c Blue (Invitrogen). Purifi  ed anti-CD8 mAb was conjugated with QD705 
(Invitrogen) using standard protocols (http://drmr.com/abcon). 
  Statistical analysis.     Linear regression analysis was used to determine the 
association between (a) the percentages of CD4     T cells in BAL versus small 
intestinal lamina propria, and (b) percent CD4     T cells in BAL and absolute 
numbers of memory cells in blood versus time, and both linear regression 
and Spearman rank analysis was used to evaluate the association between 
mean plateau-phase viral loads and time to disease. A random slope model 
was used to estimate the overall decay rate of percent CD4     T cells in BAL 
and absolute numbers of memory cells in the blood in the study animals over 
time. A mixed eff  ect model was used to determine whether the size or rep-
resentation of T cell subsets in the blood or BAL signifi  cantly changed over 
the course of infection (preinfection to terminal disease), and if so, determi-
nation of which changes were most closely associated with disease. Unpaired 
  t   tests were used to determine the signifi  cance of diff  erences in (a) CD4 rep-
resentation in naive and memory compartments of PLNs, (b) peak and 
  plateau BrdU labeling in SIV-infected versus uninfected monkeys, (c) the 
representation of cells with T  EM   cell diff  erentiation among proliferating total 
memory T cells in progressive SIV infection versus controlled infection ver-
sus uninfected RMs, and (d) the level of SIV DNA content within the CD4      
T  CM  , CD8      T  CM  , and CD4      transitional memory T cell subsets of RMs in 
early plateau-phase versus end-stage SIV infection. Paired   t   tests were used 
to determine the signifi  cance of diff  erences in the level of (a) SIV DNA 
content between the CD4      T  CM   versus CD8      T  CM   versus CD4      transitional 
memory T cell subsets, and (b) post-ART proliferation between CD4      and 
CD8      T  CM   cells in PLNs. Statistical analysis was conducted with the SAS 
program (SAS Institute) and Statview (Abacus Concepts). p-values of  0.05 
were considered signifi  cant with the Bonferroni adjustment used in situa-
tions with multiple comparisons. 
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are accurate, countering this second process, the slow erosion 
of CD4      T  CM   cell homeostasis, may prove to be the most 
  eff  ective target of nonvirus-directed AIDS therapies. Interven-
tions capable of preserving or rejuvenating CD4      T  CM   cells 
might well   “  reset the clock  ”   with respect to disease progression 
and provide signifi  cant increases in AIDS-free survival. 
  MATERIALS AND METHODS 
  Animals and viruses.     A total of 71 purpose-bred male RMs (  Macaca mu-
latta  ) of Indian genetic background and free of Cercopithicine herpesvirus 1, 
D type simian retrovirus, and simian T lymphotrophic virus type 1 infection 
were used in this study: 37 infected with wild-type SIVmac239, 19 with 
SIVmac239(       nef    ), and 15 uninfected controls (  15, 56, 57  ). 14 SIVmac239-
infected and 4 SIVmac239(       nef    )-infected RMs were studied longitudinally 
for virologic or immunologic parameters or both; the remaining animals 
were used in one or more cross-sectional analyses. Early infection data 
( 200 d) on the longitudinally studied SIVmac239- and SIVmac239(       nef    )-
infected RMs have been reported (  15  ). SIVmac239 and SIVmac239(       nef    ) 
infections were initiated with intravenous injection of 5-ng equivalents of 
SIV p27 (2.7  –  3.0       10  4   infectious centers), as described previously (  15  ). 
ART consisted of daily subcutaneous injections of 30 mg/kg 9-R-(2-
phosphonomethoxypropyl)adenine (tenofovir) and 30 mg/kg      -2  ’  ,3     -
dideoxy-3     -thia-5-fl  uorocytidine (emtricitabine) (  58  ). BAL and small intestinal 
biopsies were performed as described previously (  15  ). BrdU (Sigma-Aldrich) 
was prepared as described previously (  15  ) and administered intravenously in 
three separate doses of 30 mg/kg body weight over a 24-h period. All RMs 
were housed at the Oregon National Primate Research Center in accor-
dance with standards of the Center  ’  s Animal Care and Use Committee 
and the National Institutes of Health (NIH) Guide for the Care and Use of 
Laboratory Animals (  59  ). RMs that developed disease states that were not 
clinically manageable were killed in accordance with the recommendations 
of the Panel on Euthanasia of the American Veterinary Medical Associa-
tion (  60  ). End-stage AIDS was defi  ned by the presence of AIDS-defi  ning 
opportunistic infections, wasting syndrome unresponsive to therapy, or non-
Hodgkin lymphoma (  52, 61  ). 
  Viral quantifi  cation.     Plasma SIV RNA was assessed using a real-time RT-
PCR assay (threshold sensitivity      100 SIV gag RNA copy Eq/ml of plasma; 
interassay CV  25%) (  62, 63  ). Cell-associated SIV DNA was also quantifi  ed 
by real-time PCR (sensitivity   single copy of gag DNA) using parallel 
quantifi  cation of albumin gene copy number to defi  ne total cell number in a 
sample, as described previously (  47  ). When no viral DNA was amplifi  ed from 
a given cell population, we report half the lower limit of detection (  47  ). 
  Flow cytometric analysis and sorting.     PBMCs, PLN cells, BAL cells, 
and intestinal mucosal cells were obtained and stained for fl  ow cytometric 
analysis as described previously (  15, 17, 64  ). Six-parameter fl  ow cytometric 
analysis was performed on a Becton Dickinson FACSCalibur instrument 
using FITC, PE, peridinin chlorophyl protein-Cy5.5 (PerCP-Cy5.5), and 
  allophycocyanin (APC) as the four fl  uorescent parameters. Polychromatic 
(8  –  12 parameter) fl  ow cytometric analysis was performed on an LSR II 
Becton Dickinson instrument using Pacifi  c Blue, AmCyan, FITC, PE, PE-
Texas Red, PE-Cy7, PerCP-Cy5.5, APC, APC-Cy7, and Alexa 700 as the 
available fl  uorescent parameters. Cell sorting was performed on a Becton 
Dickinson FACS ARIA at 70 PSI using FITC, PE, PE-Cy5, PE-Texas Red, 
APC, APC-Cy7, and QD-705 as fl  uorescent parameters. Instrument set-up, 
data acquisition, and sorting procedures were performed as described previ-
ously (  47, 65, 66  ). List mode multiparameter data fi  les were analyzed using 
the FlowJo software program (version 6.3.1; Tree Star, Inc.). 
  Memory and naive T cell subsets were delineated based on CD28,      7-
integrin, CCR7, CCR5, and CD95 expression patterns on gated CD4      or 
CD8      T cells, as described previously (  18, 64, 66  ). In brief, naive cells con-
stitute a uniform cluster of cells with a CD28  moderate  ,      7-integrin  moderate  , 
CCR7  moderate  , CCR5    −   , CD95  low   phenotype, which is clearly distinguishable 2184 DETERMINANTS OF PROGRESSION IN CHRONIC SIV INFECTION | Okoye et al.
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